Clinical trial

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With…

NCT00049595 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00049595
Title Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
Official title BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators Lymphoma Trials Office Lymphoma Study Association Grup per l'Estudi dels Limfomes de Catalunya i Balears NCIC Clinical Trials Group Australasian Leukaemia and Lymphoma Group Nordic Lymphoma Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Biological, Drug
Interventions bleomycin sulfate, filgrastim, pegfilgrastim, ABVD regimen, BEACOPP regimen, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, prednisone and 3 more
Enrollment 552
Start date Aug 1, 2002
Primary completion Jan 1, 2010
First posted Jan 27, 2003
Last update posted Aug 5, 2025
Countries Australia, Belgium, Canada, Croatia, Czechia, France, Hungary, Netherlands, New Zealand, Poland, Spain, Sweden and 1 more

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies